FDA
-
-
-
-
-
-
-
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
-
-
-
-
-
-
-
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
-
-
-
-
-
-
-
Inspira Technologies (IINN) Unveils the INSPIRA ART Line of Medical Devices
-
-
-
-
-
-
-
Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
-
-
-
-
-
-
-
Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
-
-
-
-
-
-
-
Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market
-
-
-
-
-
-
-
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
-
251,957 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All